News
TipRanks on MSN20h
GSK’s Promising Study on Belimumab for Lung Disease: What Investors Need to Know
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
Use of belimumab prior to vs after initiating immunosuppressants was linked to faster OGC tapering and fewer disease flares among patients with SLE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback